Last reviewed · How we verify

NCT03109678

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

Completed NA Last updated 12 April 2017
What this trial tests

NA trial testing Crossover Ambu Aura-i™ / Rüsch Super Safety Silk™ in Airway Management in 80 participants. Completed in 7 March 2012.

Timeline
12 July 2011
Primary endpoint
7 March 2012
7 March 2012

Quick facts

Lead sponsorAsklepios Kliniken Hamburg GmbH
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposedevice feasibility
Enrollment80
Start date12 July 2011
Primary completion7 March 2012
Estimated completion7 March 2012

Drugs / interventions tested

Conditions studied

Sponsor

Asklepios Kliniken Hamburg GmbH — full company profile →

Who can join

Adults 15 to 80, any sex, with Airway Management or Laryngeal Mask Airway. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intubating laryngeal mask Fastrach™ is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. Recently, a single use version of the mask has been introduced. The Fastrach single use laryngeal mask is beng compared to the new, low-priced single use intubating laryngeal mask Ambu Aura-i™.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A comparison of blind intubation with the intubating laryngeal mask FASTRACH™ and the intubating laryngeal mask Ambu Aura-i™ a prospective randomised clinical trial.
    Schiewe R, Stoeck M, Gruenewald M, Hoecker J, et al · · 2019 · cited 3× · PMID 30927922 · DOI 10.1186/s12871-019-0718-6

Verify or expand the search:

Other recruiting trials for Airway Management

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing